Abeona Therapeutics (ABEO) Cash & Current Investments: 2011-2025
Historic Cash & Current Investments for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $207.5 million.
- Abeona Therapeutics' Cash & Current Investments rose 88.53% to $207.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $684.1 million, marking a year-over-year increase of 96.39%. This contributed to the annual value of $98.1 million for FY2024, which is 86.55% up from last year.
- Per Abeona Therapeutics' latest filing, its Cash & Current Investments stood at $207.5 million for Q3 2025, which was down 8.15% from $225.9 million recorded in Q2 2025.
- Abeona Therapeutics' Cash & Current Investments' 5-year high stood at $225.9 million during Q2 2025, with a 5-year trough of $23.5 million in Q3 2022.
- For the 3-year period, Abeona Therapeutics' Cash & Current Investments averaged around $105.8 million, with its median value being $98.1 million (2024).
- In the last 5 years, Abeona Therapeutics' Cash & Current Investments crashed by 66.91% in 2022 and then skyrocketed by 231.57% in 2024.
- Quarterly analysis of 5 years shows Abeona Therapeutics' Cash & Current Investments stood at $50.9 million in 2021, then increased by 3.09% to $52.5 million in 2022, then rose by 0.15% to $52.6 million in 2023, then skyrocketed by 86.55% to $98.1 million in 2024, then skyrocketed by 88.53% to $207.5 million in 2025.
- Its last three reported values are $207.5 million in Q3 2025, $225.9 million for Q2 2025, and $152.7 million during Q1 2025.